MENOPUR in Gonadotrophin-releasing Hormone (GnRH) Antagonist Cycles With Single Embryo Transfer
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The main purpose of this clinical research trial was to compare the ongoing pregnancy rate
between two gonadotrophins for controlled ovarian stimulation (MENOPUR and recombinant
follicle-stimulating hormone (FSH)), in cycles where a gonadotrophin-releasing hormone (GnRH)
antagonist was used for prevention of premature luteinizing hormone (LH) surge and where a
single embryo was transferred at the blastocyst stage.